261 related articles for article (PubMed ID: 24012623)
21. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
Geula C; Slevin JT
Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
[TBL] [Abstract][Full Text] [Related]
22. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
23. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
[TBL] [Abstract][Full Text] [Related]
24. Partial lesion of dopamine neurons of rat substantia nigra impairs conditioned place aversion but spares conditioned place preference.
Lima BF; Ramos DC; Barbiero JK; Pulido L; Redgrave P; Robinson DL; Gómez-A A; Da Cunha C
Neuroscience; 2017 May; 349():264-277. PubMed ID: 28279753
[TBL] [Abstract][Full Text] [Related]
25. Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons.
Aumann TD; Egan K; Lim J; Boon WC; Bye CR; Chua HK; Baban N; Parish CL; Bobrovskaya L; Dickson P; Horne MK
J Neurochem; 2011 Feb; 116(4):646-58. PubMed ID: 21166807
[TBL] [Abstract][Full Text] [Related]
26. Dual effects of L-DOPA on nigral dopaminergic neurons.
Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
[TBL] [Abstract][Full Text] [Related]
27. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
[TBL] [Abstract][Full Text] [Related]
28. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
Aumann TD
J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
[TBL] [Abstract][Full Text] [Related]
29. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK
J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136
[TBL] [Abstract][Full Text] [Related]
30. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
32. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
[TBL] [Abstract][Full Text] [Related]
33. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
[TBL] [Abstract][Full Text] [Related]
34. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
[TBL] [Abstract][Full Text] [Related]
35. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
[TBL] [Abstract][Full Text] [Related]
36. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.
Bouali-Benazzouz R; Tai CH; Chetrit J; Benazzouz A
Neuroscience; 2009 Dec; 164(2):588-96. PubMed ID: 19628021
[TBL] [Abstract][Full Text] [Related]
37. Glutamate-mediated [Ca2+]c dynamics in spontaneously firing dopamine neurons of the rat substantia nigra pars compacta.
Choi YM; Kim SH; Uhm DY; Park MK
J Cell Sci; 2003 Jul; 116(Pt 13):2665-75. PubMed ID: 12746490
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
Rice ME; Cragg SJ; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):853-62. PubMed ID: 9065854
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
40. Beyond the basal ganglia: cFOS expression in the cerebellum in response to acute and chronic dopaminergic alterations.
Herrera-Meza G; Aguirre-Manzo L; Coria-Avila GA; Lopez-Meraz ML; Toledo-Cárdenas R; Manzo J; Garcia LI; Miquel M
Neuroscience; 2014 May; 267():219-31. PubMed ID: 24631673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
